|
OLA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.674600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.041400E-01 |
| Normal-vs-Stage2 |
6.399200E-01 |
| Normal-vs-Stage3 |
9.851800E-01 |
| Normal-vs-Stage4 |
5.166400E-01 |
| Stage1-vs-Stage2 |
9.818000E-01 |
| Stage1-vs-Stage3 |
3.955400E-01 |
| Stage1-vs-Stage4 |
9.254200E-01 |
| Stage2-vs-Stage3 |
6.108600E-01 |
| Stage2-vs-Stage4 |
9.318800E-01 |
| Stage3-vs-Stage4 |
5.119800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.780000E-01 |
| Normal-vs-AfricanAmerican |
1.847840E-01 |
| Normal-vs-Asian |
5.366800E-01 |
| Caucasian-vs-AfricanAmerican |
2.933200E-01 |
| Caucasian-vs-Asian |
7.138200E-01 |
| AfricanAmerican-vs-Asian |
4.085800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.498200E-01 |
| Normal-vs-Female |
6.675400E-01 |
| Male-vs-Female |
4.726400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.202600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.635400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.905400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.000600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.976200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.766400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.871000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.069200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.915800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.875800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.392600E-01 |
| Classical-VS-Follicular |
3.040200E-01 |
| Classical-VS-Other |
3.244200E-01 |
| Classical-VS-Normal |
3.124200E-01 |
| Tall-VS-Follicular |
6.015000E-01 |
| Tall-VS-Other |
4.590200E-01 |
| Tall-VS-Normal |
5.921800E-01 |
| Follicular-VS-Other |
2.927800E-01 |
| Follicular-VS-Normal |
9.871800E-01 |
| Other-VS-Normal |
1.809980E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.988000E-01 |
| Normal-vs-N1 |
6.148400E-01 |
| N0-vs-N1 |
5.000400E-01 |
|
|
